BPC-157 also engages the nitric oxide (NO) system by modulating eNOS (endothelial nitric oxide synthase) activity
It points to people with conditions that interfere with absorption, naming irritable bowel syndrome, celiac disease and chronic reflux as examples where the oral form may be poorly absorbed
Do we all turn into boring, listless people? A small minority of the population seems to report anhedonia after taking GLP-1s, and other mental-health consequencesirritability, insomnia, apathy, brain fogare probably only slightly more common
Supports detoxification, immunity, antioxidant protection, and overall vitality
Open communication about appetite changes, energy levels, and gastrointestinal comfort ensures your dose and medication choice optimize both efficacy and tolerability